[Nephron sparing in the management of localized solid renal mass].
暂无分享,去创建一个
J. Bibault | C. Dariane | O. Hélénon | J. Correas | O. Hélénon | J. Correas | M. Timsit | A. Méjean | V. Verkarre | M. Timsit | A. Méjean | J. Bibault | V. Verkarre | S. Bodard | S. Guinebert | C. Delavaud | S. Bodard | I. Boudhabhay | C. Dariane | Christophe Delavaud | S. Guinebert | Idris Boudhabhay | Sylvain Guinebert | Sylvain Bodard
[1] O. Hélénon,et al. [Cancer imaging and prevention of renal failure]. , 2022, Bulletin du Cancer.
[2] J. Bernhard,et al. French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer. , 2022, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.
[3] O. Hélénon,et al. Percutaneous Thermal Ablation for Renal Tumors in Patients with Birt–Hogg–Dubé Syndrome , 2022, Cancers.
[4] M. Ferro,et al. Quality of Life and Psychological Distress among Patients with Small Renal Masses , 2022, Journal of clinical medicine.
[5] S. Hancock,et al. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.
[6] J. Correas,et al. Disease Progression in Older Patients With Renal Tumor Assigned to an Active Surveillance Protocol. , 2021, Clinical genitourinary cancer.
[7] J. Cadeddu,et al. Radiofrequency Ablation of Small Renal Masses. , 2021, Journal of endourology.
[8] R. Clayman,et al. Can preoperative renal mass biopsy change clinical practice and reduce surgical intervention for small renal masses? , 2021, Urologic oncology.
[9] B. Lane,et al. Utilization of Renal Mass Biopsy for T1 Renal Lesions across Michigan: Results from MUSIC-KIDNEY, A Statewide Quality Improvement Collaborative , 2021, European urology open science.
[10] Sam S. Chang,et al. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II. , 2021, The Journal of urology.
[11] Sam S. Chang,et al. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I , 2021, The Journal of urology.
[12] K. Bensalah,et al. Percutaneous Ablation Versus Surgical Resection for Local Recurrence Following Partial Nephrectomy for Renal Cell Cancer: A Propensity Score Analysis (REPART Study-UroCCR 71). , 2021, European urology focus.
[13] Laurentiu M. Pop,et al. Neoadjuvant SAbR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus - Safety Lead-in Results of a Phase II Trial. , 2021, International journal of radiation oncology, biology, physics.
[14] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[15] A. Jemal,et al. Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.
[16] P. Pierorazio,et al. Outcomes of Active Surveillance for Young Patients with Small Renal Masses: Prospective Data from the DISSRM Registry. , 2020, The Journal of urology.
[17] K. Bensalah,et al. [French ccAFU guidelines - update 2020-2022: management of kidney cancer]. , 2020, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.
[18] X. Cathelineau,et al. Renal Tumor Biopsy: Rationale to Avoid Surgery in Small Renal Masses , 2020, Current Urology Reports.
[19] K. Bensalah,et al. Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel. , 2020, European urology oncology.
[20] K. Bensalah,et al. What Is Better for Predicting Morbidity of Robotic Partial Nephrectomy-A Score or Your Clinical Judgement? , 2020, European urology focus.
[21] A. Levey,et al. Chronic Kidney Disease and Kidney Cancer Surgery: New Perspectives. , 2020, The Journal of urology.
[22] M. Nielsen,et al. Management of small renal masses in patients with chronic kidney disease: Perspectives from a nephrologist. , 2019, Urologic oncology.
[23] H. Cathro,et al. Does renal mass biopsy influence multidisciplinary treatment recommendations? , 2019, Scandinavian journal of urology.
[24] I. Kaplan,et al. Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). , 2019, International journal of radiation oncology, biology, physics.
[25] J. Cheville,et al. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. , 2019, European urology.
[26] S. Kanazawa,et al. Percutaneous thermal ablation for renal cell carcinoma in patients with Birt-Hogg-Dubé syndrome. , 2019, Diagnostic and interventional imaging.
[27] I. Wu,et al. Higher risk of malignant neoplasms in young adults with end‐stage renal disease receiving haemodialysis: A nationwide population‐based study , 2019, Nephrology.
[28] F. Bray,et al. Epidemiology of Renal Cell Carcinoma. , 2019, European urology.
[29] S. Pal,et al. Distress in patients with renal cell carcinoma: a curious gap in knowledge , 2018, BJU international.
[30] V. Khoo,et al. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II , 2018, BMC Cancer.
[31] J. Kaouk,et al. The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. , 2018, European urology oncology.
[32] G. Rücker,et al. Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis , 2018, European Radiology.
[33] C. Wood,et al. Conditional survival of patients with small renal masses undergoing active surveillance , 2018, BJU international.
[34] B. Trock,et al. Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study , 2018, BJU international.
[35] Coral L. Atoria,et al. Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer , 2018, Annals of Internal Medicine.
[36] Kathryn J Fowler,et al. Quantitative multiparametric MR analysis of small renal lesions: correlation with surgical pathology , 2018, Abdominal radiology.
[37] C. Dietrich,et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version) , 2018, Ultraschall in der Medizin - European Journal of Ultrasound.
[38] I. Kaplan,et al. Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) , 2018, Cancer.
[39] O. Hakenberg,et al. Analysis of psychosocial stress factors in patients with renal cancer , 2018, Therapeutic advances in urology.
[40] P. Tamboli,et al. Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses , 2018, The Journal of urology.
[41] E. Bass,et al. Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.
[42] Anurag K. Singh,et al. A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma , 2017, Clinical Cancer Research.
[43] F. Cornelis,et al. The future of percutaneous renal ablation. , 2017, Diagnostic and interventional imaging.
[44] A. Finelli,et al. Safety, reliability and accuracy of small renal tumour biopsies: results from a multi‐institution registry , 2017, BJU international.
[45] Charles Swanton,et al. Renal cell carcinoma , 2017, Nature Reviews Disease Primers.
[46] F. Orsi,et al. CIRSE Guidelines on Percutaneous Ablation of Small Renal Cell Carcinoma , 2017, CardioVascular and Interventional Radiology.
[47] A. Evans,et al. Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] David C. Miller,et al. Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision? , 2016, Urology.
[49] B. Trock,et al. A Prospective, Comparative Study of Quality of Life among Patients with Small Renal Masses Choosing Active Surveillance and Primary Intervention. , 2016, The Journal of urology.
[50] Konstantinos Katsanos,et al. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma , 2016, CardioVascular and Interventional Radiology.
[51] D. Serie,et al. Mayo Adhesive Probability Score Is Associated With Localized Renal Cell Carcinoma Progression-free Survival. , 2016, Urology.
[52] A. Evans,et al. Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year Experience. , 2015, European urology.
[53] Mark W. Ball,et al. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry. , 2015, European urology.
[54] U. Capitanio,et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. , 2015, European urology.
[55] J. Cheville,et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. , 2015, European urology.
[56] E. Jonasch,et al. Psychological states, serum markers and survival: associations and predictors of survival in patients with renal cell carcinoma , 2015, Journal of Behavioral Medicine.
[57] T. Vogl,et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. , 2014, Radiology.
[58] L. Kuller,et al. Hypertension and Obesity and the Risk of Kidney Cancer in 2 Large Cohorts of US Men and Women , 2014, Hypertension.
[59] E. Messing,et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. , 2014, European urology.
[60] K. Katsanos,et al. Systematic Review and Meta-Analysis of Thermal Ablation Versus Surgical Nephrectomy for Small Renal Tumours , 2014, CardioVascular and Interventional Radiology.
[61] S. Bhayani,et al. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours , 2013, BJU international.
[62] Md. Shad Akhtar,et al. Active surveillance of small renal masses offers short‐term oncological efficacy equivalent to radical and partial nephrectomy , 2012, BJU international.
[63] R. Uzzo,et al. Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. , 2011, European urology.
[64] A. Evans,et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. , 2011, European urology.
[65] K. Bensalah,et al. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. , 2010, European urology.
[66] Robert G Uzzo,et al. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. , 2009, The Journal of urology.
[67] O. Hes,et al. Tumours in end-stage kidney. , 2008, Transplantation proceedings.
[68] M. Cooperberg,et al. Renal cell cancer stage migration , 2008, Cancer.
[69] G Scott Gazelle,et al. Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. , 2008, Radiology.
[70] K. Bensalah,et al. Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma. , 2008, European urology.
[71] M. Schonlau,et al. Renal and cardiovascular morbidity after partial or radical nephrectomy , 2008, Cancer.
[72] I. Gill,et al. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. , 2006, The Journal of urology.
[73] Andrew J Vickers,et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. , 2006, The Lancet. Oncology.
[74] F. Kondylis,et al. The natural history of incidentally detected small renal masses , 2004, Cancer.
[75] M. Pearle,et al. Laparoscopic interstitial laser coagulation of renal tissue with and without hilar occlusion in the porcine model. , 2002, Journal of endourology.
[76] M Jayson,et al. Increased incidence of serendipitously discovered renal cell carcinoma. , 1998, Urology.
[77] M. A. Lotfi,et al. Laparoscopic interstitial contact laser ablation of renal lesions: an experimental model. , 1994, Journal of endourology.
[78] C. Porta,et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[79] P. Pierorazio,et al. Use of delayed intervention for small renal masses initially managed with active surveillance. , 2019, Urologic oncology.
[80] P. Pierorazio,et al. Renal Mass Biopsy is Associated with Reduction in Surgery for Early-Stage Kidney Cancer. , 2019, Urology.
[81] K. Bensalah,et al. [CCAFU french national guidelines 2016-2018 on renal cancer]. , 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.